Profitability of hypolipidemic drug treatments
Subías Lorén, P.J.; Ginés García, C.
Medicina Clinica 107(1): 37
1996
ISSN/ISBN: 0025-7753 PMID: 8709673 Document Number: 455218
Document emailed within 1 workday
Related Documents
Pickart, L. 1981: Suppression of acute-phase synthesis of fibrinogen by a hypolipidemic drug (clofibrate) International Journal of Tissue Reactions 3(2): 65-72Taheri Zadeh, Z.; Rahmani, S.; Alidadi, F.; Joushi, S.; Esmaeilpour, K. 2021: Depresssion, anxiety and other cognitive consequences of social isolation: Drug and non-drug treatments International Journal of Clinical Practice 75(12): E14949
Chen, H.T.; Tuner, N.; Chen, C.J.; Lin, H.-y.; Liang, S.; Wang, S. 2013: Correlations between compulsory drug abstinence treatments and HIV risk behaviors among injection drug users in a border city of South China Aids Education and Prevention: Official Publication of the International Society for Aids Education 25(4): 336-348
Ravaud, P. 2002: Non-drug treatments for osteoarthritis Presse Medicale 31(39 Part 2): 4s10-4s12
Haukkamaa, M. 1987: Hormonal contraception and other drug treatments Duodecim; Laaketieteellinen Aikakauskirja 103(9): 598-602
Kripke, C. 2004: Drug treatments for patients with dysthymia American Family Physician 70(7): 1269-1270
Bronnert, J. 2006: The codes and treatments for drug and alcohol conditions Journal of Ahima 77(5): 80-82
Carpentier, J.; Bloch-Lainé, J.F.; Hefez, S. 1994: Value and limitations of substitution treatments in the care of drug addicts Annales de Medecine Interne 145(Suppl 3): 50-51
O'Sullivan; Curzon 1998: Drug treatments for asthma may cause erosive tooth damage Bmj 317(7161): 820
Patraş, E. 1983: Correlations between candidiasis of the buccal cavity and various drug treatments Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 87(4): 609-611
Kurland, M.L. 1976: Neurotic depression an empirical guide to two specific drug treatments Diseases of the Nervous System 37(8): 424-431
Moorhead, L.C.; Sepahban, S.; Armeniades, C.D. 1991: Evaluation of drug treatments for proliferative vitreoretinopathy using vitreous microtensiometry Annals of Ophthalmology 23(9): 349-355
Saliba, E.; Laugier, J. 1993: Drug treatments of respiratory distress syndrome in premature infants Pediatrie 48(12): 864-871
Dickson, P.I. 2009: Novel treatments and future perspectives: outcomes of intrathecal drug delivery International Journal of Clinical Pharmacology and Therapeutics 47(Suppl 1): S124-S127
Fourcroy, J.L. 1998: Issues and priorities in the development of drug treatments for female sexual dysfunction International Journal of Impotence Research 10 Suppl. 2: S121-S123
Binder, P. 1994: Can the general practitioner care for outpatient drug addicts without substitution treatments? what products can he use? Annales de Medecine Interne 145(Suppl 3): 62-64
Hayashi, T. 2005: Fuzeon, first of the so-called "fusion inhibitor" drug in new class of AIDS treatments and its warnings Nihon Rinsho. Japanese Journal of Clinical Medicine 63(1): 173-182
Saturno Hernández, P.J.; Gascón Cánovas, J.J. 1997: The validity of therapeutic utility and intrinsic value as indicators of drug prescription quality: an analysis of treatments in cases of the common cold Atencion Primaria 19(8): 400-406
Clarke, R.L. 1999: Profitability is no measure of viability Healthcare Financial Management: Journal of the Healthcare Financial Management Association 53(3): 16
Floret, D. 1993: Suppurative meningitis in infants and in children: adjuvant treatments and treatments of neurological forms Pediatrie 48(1): 21-27